10-Feb-2014

Sail Newport Presents Thursday Night

Featuring Bristol, RI's Charlie Enright's Announcement to Enter Volvo Ocean Race on Team Alvimedica

A seven-year dream is coming true for American sailors as Bristol, RI's Charlie Enright (pictured left) announced his Team Alvimedica's challenge for the 2014-15 edition of the Volvo Ocean Race. This is exciting news for the U.S. sailing community which will follow the American skipper and Team Alvimedica - also expected to be the youngest team of sailors in the ocean marathon.

The team will also include American Mark Towill (Hawaii). Enright and Towill met during the production of the Disney movie Morning Light and set their sights on mounting a campaign to compete in the Volvo Ocean Race.

Sail Newport Presents, supported by Fidelity Investments, will be held on Thursday, February 13 at 5:30 p.m. to debut the team's plans to prepare for the grueling "Mt. Everest of sailing" ocean race which will circumnavigate the globe.PURCHASE TICKETS FOR THURSDAY NIGHT

The event will feature dynamic on-screen footage of the race, information on the team, the boats, the stopovers and how the Newport community can plan a celebration for the Rhode Island skipper.

Team Alvimedica will join Team SCA (with fellow American Sally Barkow onboard), Abu Dhabi Ocean Racing, Dongfeng Race Team and Team Brunel in the race which will be contested over 38,739 nautical miles and nine months. The race starts in October in Alicante, Spain and finishes in Gothenburg, Sweden in June of 2015. The only North American stop over will take place May 5-17, 2015. The boats will arrive in Newport from a stopover in Itajai, Brazil and will depart Newport on May 17, 2015 for the Transatlantic race leg to Lisbon, Portugal.

visit: www.volvooceanrace.com

Tickets to the event can be purchased online
The cost is $15 for adults and $5 for under 18
*This event will sell out so order tickets immediately

Jane Pickens Theater, Washington Square
Newport, RI

For more information: katie.barker@sailnewport.org

TEAM ALVIMEDICA ANNOUNCEMENT

 

< Back to News and Press